CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Real-world effectiveness of Ledipasvir/Sofosbuvir 8 weeks chronic hepatitis C treatment
DOI 10.1055/s-0035-1559188
Bibliografische Angaben
Nachweis in CareLit
Autor:innenP Buggisch, J Petersen, K Wursthorn, A Gauthier, P Atanasov
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe08/2015
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background and Aims: Ledipasvir/Sofosbuvir (LDV/SOF) single tablet regimen (STR) is approved in Europe for chronic hepatitis C (CHC) patients with genotypes (GT) 1, 3 and 4. In the ION-3 study 8 weeks (8w) of LDV/SOF was non-inferior to 12 w in previously untreated GT1 patients without cirrhosis with no benefit for the addition of Ribavirin. According to the SPC 8w may be considered in this population. The aim of th…
Zitieren
Zitierempfehlung
P Buggisch, J Petersen, K Wursthorn, A Gauthier, P Atanasov (2015) Real-world effectiveness of Ledipasvir/Sofosbuvir 8 weeks chronic hepatitis C treatment. Zeitschrift für Gastroenterologie (08). https://doi.org/10.1055/s-0035-1559188
Mit CareLit weiterarbeiten